Cloning, expression, and functional characterization of TL1A-Ig

Journal of Immunology

Volumn 190, Issue 4, 2013, Pages 1540-1550

  Khan, Samia Q ^a   Tsai, Matthew S ^a   Schreiber, Taylor H ^a   Wolf, Dietlinde ^a   Deyev, Vadim V ^a   Podack, Eckhard R ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD103 ANTIGEN; CELL PROTEIN; DEATH RECEPTOR 3; HYBRID PROTEIN; IMMUNOGLOBULIN G1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN KLRG1; TNF SUPERFAMILY MEMBER 15 IMMUNOGLOBULIN FUSION PROTEIN; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CARBOXY TERMINAL SEQUENCE; CD4 LYMPHOCYTE PERCENTAGE; CD4+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MOLECULAR CLONING; MOLECULAR MODEL; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; CELL LINE, TUMOR; CHO CELLS; CLONING, MOLECULAR; CRICETINAE; FLOW CYTOMETRY; GENES, REPORTER; IMMUNOGLOBULIN HEAVY CHAINS; MICE; MICE, INBRED C57BL; MUTAGENESIS, INSERTIONAL; NIH 3T3 CELLS; PLASMIDS; RECOMBINANT FUSION PROTEINS; RESPIRATORY HYPERSENSITIVITY; TRANSFECTION; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15;

EID: 84873546540     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201908     Document Type: Article

References (49)

1. Croft, M. 2009. The role of TNF superfamily members in T-cell function and diseases. Nat. Rev. Immunol. 9: 271-285.
2. Chinnaiyan, A. M., K. O'Rourke, G. L. Yu, R. H. Lyons, M. Garg, D. R. Duan, L. Xing, R. Gentz, J. Ni, and V. M. Dixit. 1996. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 274: 990-992.
3. Kitson, J., T. Raven, Y. P. Jiang, D. V. Goeddel, K. M. Giles, K. T. Pun, C. J. Grinham, R. Brown, and S. N. Farrow. 1996. A death-domain-containing receptor that mediates apoptosis. Nature 384: 372-375.
4. Marsters, S. A., J. P. Sheridan, C. J. Donahue, R. M. Pitti, C. L. Gray, A. D. Goddard, K. D. Bauer, and A. Ashkenazi. 1996. Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-kB. Curr. Biol. 6: 1669-1676.
5. Bodmer, J. L., K. Burns, P. Schneider, K. Hofmann, V. Steiner, M. Thome, T. Bornand, M. Hahne, M. Schröter, K. Becker, et al. 1997. TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). Immunity 6: 79-88.
6. Screaton, G. R., X. N. Xu, A. L. Olsen, A. E. Cowper, R. Tan, A. J. McMichael, and J. I. Bell. 1997. LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proc. Natl. Acad. Sci. USA 94: 4615-4619.
7. Tan, K. B., J. Harrop, M. Reddy, P. Young, J. Terrett, J. Emery, G. Moore, and A. Truneh. 1997. Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells. Gene 204: 35-46.
8. Fang, L., B. Adkins, V. Deyev, and E. R. Podack. 2008. Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation. J. Exp. Med. 205: 1037-1048.
9. Migone, T. S., J. Zhang, X. Luo, L. Zhuang, C. Chen, B. Hu, J. S. Hong, J. W. Perry, S. F. Chen, J. X. Zhou, et al. 2002. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 16: 479-492.
10. Zhan, C., Q. Yan, Y. Patskovsky, Z. Li, R. Toro, A. Meyer, H. Cheng, M. Brenowitz, S. G. Nathenson, and S. C. Almo. 2009. Biochemical and structural characterization of the human TL1A ectodomain. Biochemistry 48: 7636-7645.
11. Prehn, J. L., L. S. Thomas, C. J. Landers, Q. T. Yu, K. S. Michelsen, and S. R. Targan. 2007. The T cell costimulator TL1A is induced by FcgR signaling in human monocytes and dendritic cells. J. Immunol. 178: 4033-4038.
12. Bamias, G., M. Mishina, M. Nyce, W. G. Ross, G. Kollias, J. Rivera-Nieves, T. T. Pizarro, and F. Cominelli. 2006. Role of TL1A and its receptor DR3 in two models of chronic murine ileitis. Proc. Natl. Acad. Sci. USA 103: 8441-8446.
13. Meylan, F., T. S. Davidson, E. Kahle, M. Kinder, K. Acharya, D. Jankovic, V. Bundoc, M. Hodges, E. M. Shevach, A. Keane-Myers, et al. 2008. The TNFfamily receptor DR3 is essential for diverse T cell-mediated inflammatory diseases. Immunity 29: 79-89.
14. Taraban, V. Y., T. J. Slebioda, J. E. Willoughby, S. L. Buchan, S. James, B. Sheth, N. R. Smyth, G. J. Thomas, E. C. Wang, and A. Al-Shamkhani. 2011. Sustained TL1A expression modulates effector and regulatory T-cell responses and drives intestinal goblet cell hyperplasia. Mucosal Immunol. 4: 186-196.
15. + regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3: 135-142.
16. + T cells. J. Immunol. 173: 5008-5020.
17. Ji, H. B., G. Liao, W. A. Faubion, A. C. Abadía-Molina, C. Cozzo, F. S. Laroux, A. Caton, and C. Terhorst. 2004. Cutting edge: the natural ligand for glucocorticoid-induced TNF receptor-related protein abrogates regulatory T cell suppression. J. Immunol. 172: 5823-5827.
18. + T cells. J. Immunol. 179: 1427-1430.
19. + Tregs. Blood 110: 2501-2510.
20. + Tregs. Transplantation 85: 1659-1662.
21. Schreiber, T. H., D. Wolf, M. S. Tsai, J. Chirinos, V. V. Deyev, L. Gonzalez, T. R. Malek, R. B. Levy, and E. R. Podack. 2010. Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammation. J. Clin. Invest. 120: 3629-3640.
22. Koreth, J., K. Matsuoka, H. T. Kim, S. M. McDonough, B. Bindra, E. P. Alyea, III, P. Armand, C. Cutler, V. T. Ho, N. S. Treister, et al. 2011. Interleukin-2 and regulatory T cells in graft-versus-host disease. N. Engl. J. Med. 365: 2055-2066.
23. Liu, C. L., P. Ye, B. C. Yen, and C. H. Miao. 2011. In vivo expansion of regulatory T cells with IL-2/IL-2 mAb complexes prevents anti-factor VIII immune responses in hemophilia A mice treated with factor VIII plasmid-mediated gene therapy. Mol. Ther. 19: 1511-1520.
24. Xiao, X., W. Gong, G. Demirci, W. Liu, S. Spoerl, X. Chu, D. K. Bishop, L. A. Turka, and X. C. Li. 2012. New insights on OX40 in the control of T cell immunity and immune tolerance in vivo. J. Immunol. 188: 892-901.
25. Wan, Y. Y., and R. A. Flavell. 2005. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc. Natl. Acad. Sci. USA 102: 5126-5131.
26. Strbo, N., K. Yamazaki, K. Lee, D. Rukavina, and E. R. Podack. 2002. Heat shock fusion protein gp96-Ig mediates strong CD8 CTL expansion in vivo. Am. J. Reprod. Immunol. 48: 220-225.
27. Gillies, S. D., and J. S. Wesolowski. 1990. Antigen binding and biological activities of engineered mutant chimeric antibodies with human tumor specificities. Hum. Antibodies Hybridomas 1: 47-54.
28. Bebbington, C. R., G. Renner, S. Thomson, D. King, D. Abrams, and G. T. Yarranton. 1992. High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker. Biotechnology (N. Y.) 10: 169-175.
29. Zhan, C., Y. Patskovsky, Q. Yan, Z. Li, U. Ramagopal, H. Cheng, M. Brenowitz, X. Hui, S. G. Nathenson, and S. C. Almo. 2011. Decoy strategies: the structure of TL1A:DcR3 complex. Structure 19: 162-171.
30. Jin, T., F. Guo, S. Kim, A. Howard, and Y. Z. Zhang. 2007. X-ray crystal structure of TNF ligand family member TL1A at 2.1A. Biochem. Biophys. Res. Commun. 364: 1-6.
31. Jin, T., S. Kim, F. Guo, A. Howard, and Y. Z. Zhang. 2007. Purification and crystallization of recombinant human TNF-like ligand TL1A. Cytokine 40: 115-122.
32. + regulatory T cells are activated in vivo by recognition of self. Int. Immunol. 19: 557-566.
33. Ito, T., Y. H. Wang, O. Duramad, S. Hanabuchi, O. A. Perng, M. Gilliet, F. X. Qin, and Y. J. Liu. 2006. OX40 ligand shuts down IL-10-producing regulatory T cells. Proc. Natl. Acad. Sci. USA 103: 13138-13143.
34. + regulatory T cells accumulate in dendritic cell aggregates of the colonic mucosa in murine transfer colitis. Am. J. Pathol. 168: 1898-1909.
35. + regulatory T cells ameliorate ongoing chronic graft-versus-host disease. Blood 112: 2129-2138.
36. Beyersdorf, N., X. Ding, J. K. Tietze, and T. Hanke. 2007. Characterization of mouse CD4 T cell subsets defined by expression of KLRG1. Eur. J. Immunol. 37: 3445-3454.
37. Monteiro, J. P., J. Farache, A. C. Mercadante, J. A. Mignaco, M. Bonamino, and A. Bonomo. 2008. Pathogenic effector T cell enrichment overcomes regulatory T cell control and generates autoimmune gastritis. J. Immunol. 181: 5895-5903.
38. Tang, Q., J. Y. Adams, C. Penaranda, K. Melli, E. Piaggio, E. Sgouroudis, C. A. Piccirillo, B. L. Salomon, and J. A. Bluestone. 2008. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28: 687-697.
39. Thilenius, A. R., K. Braun, and J. H. Russell. 1997. Agonist antibody and Fas ligand mediate different sensitivity to death in the signaling pathways of Fas and cytoplasmic mutants. Eur. J. Immunol. 27: 1108-1114.
40. Totpal, K., R. LaPushin, T. Kohno, B. G. Darnay, and B. B. Aggarwal. 1994. TNF and its receptor antibody agonist differ in mediation of cellular responses. J. Immunol. 153: 2248-2257.
41. Barrett, R., X. Zhang, H.W. Koon, M. Vu, J. Y. Chang, N. Yeager, M. A. Nguyen, K. S. Michelsen, D. Berel, C. Pothoulakis, et al. 2012. Constitutive TL1A expression under colitogenic conditions modulates the severity and location of gut mucosal inflammation and induces fibrostenosis. Am. J. Pathol. 180: 636-649.
42. Shih, D. Q., R. Barrett, X. Zhang, N. Yeager, H. W. Koon, P. Phaosawasdi, Y. Song, B. Ko, M. H. Wong, K. S. Michelsen, et al. 2011. Constitutive TL1A (TNFSF15) expression on lymphoid or myeloid cells leads to mild intestinal inflammation and fibrosis. PLoS ONE 6: e16090.
43. Meylan, F., Y. J. Song, I. Fuss, S. Villarreal, E. Kahle, I. J. Malm, K. Acharya, H. L. Ramos, L. Lo, M. M. Mentink-Kane, et al. 2011. The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation. Mucosal Immunol. 4: 172-185.
44. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198: 1875-1886.
45. + regulatory T cells by peripheral expansion. J. Immunol. 173: 7259-7268.
46. + regulatory T cell function. J. Exp. Med. 196: 851-857.
47. Wolf, D., T. H. Schreiber, P. Tryphonopoulos, S. Li, A. G. Tzakis, P. Ruiz, and E. R. Podack. 2012. Tregs expanded in vivo by TNFRSF25 agonists promote cardiac allograft survival. Transplantation 94: 569-574.
48. J Reddy, P. B., T. H. Schreiber, N. K. Rajasagi, A. Suryawanshi, S. Mulik, T. Veiga-Parga, T. Niki, M. Hirashima, E. R. Podack, and B. T. Rouse; PB. 2012. TNFRSF25 agonistic antibody and galectin-9 combination therapy controls herpes simplex virus-induced immunoinflammatory lesions. J. Virol. 86: 10606-10620.
49. Schraven, B., and U. Kalinke. 2008. CD28 superagonists: what makes the difference in humans? Immunity 28: 591-595.